首页> 外文期刊>Epilepsia Open >Investigator‐initiated randomized controlled trials in children with epilepsy: Mission impossible?
【24h】

Investigator‐initiated randomized controlled trials in children with epilepsy: Mission impossible?

机译:研究者发起的癫痫儿童随机对照试验:不可能完成任务吗?

获取原文
获取外文期刊封面目录资料

摘要

Summary ObjectiveIn children many antiepileptic drugs (AEDs) are prescribed off-label due to a lack of well-designed randomized controlled trials (RCTs). We conducted a multicenter RCT in the Netherlands to compare levetiracetam and valproic acid as monotherapy in children with newly diagnosed epilepsy. After 2 years, we had to stop this investigator-initiated trial prematurely because the inclusion rate was too low. We analyzed the reasons for this failure, assessed the various issues involved in performing RCTs in children, and now give recommendations for future studies. MethodsA questionnaire was completed by all investigators involved in the study. It included questions about the motivation to participate and the perceived reasons for recruitment failure. We also studied literature about financial, logistic, legal, and ethical aspects of RCTs in children. ResultsMain reasons for recruitment failure were overestimation of the number of eligible AED-naive children referred by general pediatricians; personal preferences of investigators for specific antiepileptic drugs; and the extensive administrative load due to extra regulations and guidelines for children. Fundraising for investigator-initiated trials is difficult and the majority of RCTs concerning AEDs are sponsored by pharmaceutical companies. Involving children requires balancing between protection and participation; the randomization procedure and obtaining informed consent are complex for both children and parents. SignificancePerforming RCTs with AEDs in children is important but complicated by logistic, regulatory, legal, and ethical restrictions. Based on our recent experience, our advice to colleagues who are planning a similar trial would be to perform a feasibility pilot study; to set up intensive collaboration with referring pediatricians; to arrange support of a clinical trials unit and a local research nurse during the complete trial period; and to incorporate the possibility of extending the recruitment period. Major investments, both financially from governmental organizations and in time, are imperative for independent RCTs in children.
机译:摘要目标由于缺乏精心设计的随机对照试验(RCT),许多儿童均被禁止在处方中使用抗癫痫药(AED)。我们在荷兰进行了一个多中心RCT,以比较左乙拉西坦和丙戊酸作为新诊断癫痫患儿的单药治疗。 2年后,由于纳入率过低,我们不得不过早停止了这项由研究人员发起的试验。我们分析了这种失败的原因,评估了在儿童中进行RCT所涉及的各种问题,现在为以后的研究提供了建议。方法:由参与研究的所有调查人员填写调查表。它包括有关参与动机和招聘失败的感知原因的问题。我们还研究了有关儿童RCT的财务,物流,法律和道德方面的文献。结果招募失败的主要原因是高估了普通儿科医生转诊的合格AED天真儿童的数量;研究者对特定抗癫痫药的个人偏爱;以及由于针对儿童的额外法规和准则而产生的大量管理负担。为研究者启动的试验筹集资金很困难,并且大多数与AED有关的RCT由制药公司赞助。让儿童参与需要在保护和参与之间取得平衡;对于孩子和父母来说,随机化程序和获得知情同意都是很复杂的。重要性在儿童中使用AED进行RCT很重要,但由于后勤,法规,法律和道德方面的限制而变得复杂。根据我们最近的经验,我们对计划进行类似试验的同事的建议是进行可行性试点研究;与转诊儿科医生建立深入的合作关系;在整个试用期内安排临床试验部门和当地研究护士的支持;并考虑延长招聘期限的可能性。政府对儿童的独立随机对照研究必须从政府组织的财政上及时进行大量投资。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号